secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001213900-24-077513
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics posts investor presentation for Capital Markets Day on September 11, 2024
--------------------------------------------------------------------------------

- Investor presentation covers financial position, near-term catalysts, and publication roadmap.
- Presentation and webcast replay available on company's IR website at ir.moonlaketx.com.
- No specific financial results or guidance disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390024077513/0001213900-24-077513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390024077513/ea0214194-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer